EDAP TMS S.A. Submits 510(k) Filing to U.S. FDA for Sonolith I-Sys

LYON, France, Dec. 18, 2008 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that it has filed a 510(k) marketing application with the U.S. Food and Drug Administration (FDA) for its newly designed, high-end Sonolith I-Sys device.